Reinsurers must adapt strategies to align with risk introduced by GLP-1 therapies: Gallagher Re
Reinsurance News - Mar 28, 2025
Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 receptor agonists on medical trends and reinsurance. According to the report, as these therapies continue to reshape medical trends and insurance structures, reinsurance provider...
Recommended Articles
Posted: Sep 29, 2025
AHJ Miller, the reinsurance division of Miller and an independent specialist re/insurance broker, ha...
Posted: Sep 29, 2025
Athene, a retirement services company and subsidiary of Apollo Global Management, Inc., has announce...
Posted: Sep 29, 2025
While climate change could drive reinsurance volume in the long-term, softening of the market is mor...